Single-center, Randomised, Double-blind, Placebo-controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile of Single- and Multiple-dose Ascending Oral QG101-23-0 Capsules in Healthy Subjects
The study will consist of three parts: a single-dose ascending (SAD) phase (Part A) enrolling a total of five
six cohorts of healthy participants, a multiple-dose ascending (MAD) phase (Part B) enrolling 3 cohorts of healthy participants, and a food effect study (Part C).
100 项与 QG101-23-0 相关的临床结果
100 项与 QG101-23-0 相关的转化医学
100 项与 QG101-23-0 相关的专利(医药)
100 项与 QG101-23-0 相关的药物交易